Arrowstreet Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.2M Buy
102,739
+21,040
+26% +$6.6M 0.02% 542
2025
Q1
$24.9M Sell
81,699
-20,262
-20% -$6.17M 0.02% 537
2024
Q4
$33.9M Sell
101,961
-115,691
-53% -$38.4M 0.03% 470
2024
Q3
$72.7M Sell
217,652
-19,697
-8% -$6.57M 0.06% 265
2024
Q2
$97.8M Sell
237,349
-13,649
-5% -$5.62M 0.09% 198
2024
Q1
$101M Buy
250,998
+56,899
+29% +$23M 0.09% 192
2023
Q4
$59.5M Buy
194,099
+9,521
+5% +$2.92M 0.06% 238
2023
Q3
$44.7M Buy
184,578
+36,207
+24% +$8.77M 0.05% 266
2023
Q2
$35.6M Buy
148,371
+36,085
+32% +$8.67M 0.04% 302
2023
Q1
$21.1M Buy
112,286
+9,638
+9% +$1.81M 0.03% 401
2022
Q4
$21.8M Buy
102,648
+42,087
+69% +$8.94M 0.03% 376
2022
Q3
$9.52M Buy
60,561
+18,852
+45% +$2.96M 0.01% 535
2022
Q2
$6.24M Buy
41,709
+9,332
+29% +$1.4M 0.01% 566
2022
Q1
$5.3M Sell
32,377
-166,481
-84% -$27.2M 0.01% 623
2021
Q4
$43.3M Sell
198,858
-19,200
-9% -$4.18M 0.05% 312
2021
Q3
$41.3M Buy
218,058
+35,159
+19% +$6.65M 0.05% 358
2021
Q2
$32.3M Buy
182,899
+79,333
+77% +$14M 0.04% 441
2021
Q1
$17M Sell
103,566
-89,733
-46% -$14.7M 0.02% 656
2020
Q4
$26.9M Sell
193,299
-72,083
-27% -$10M 0.04% 493
2020
Q3
$29.7M Sell
265,382
-22,261
-8% -$2.49M 0.05% 411
2020
Q2
$26.8M Sell
287,643
-10,808
-4% -$1.01M 0.05% 386
2020
Q1
$21.9M Sell
298,451
-41,313
-12% -$3.03M 0.06% 278
2019
Q4
$28.6M Buy
339,764
+273,504
+413% +$23M 0.07% 300
2019
Q3
$5.57M Buy
+66,260
New +$5.57M 0.01% 676
2019
Q1
Sell
-12,347
Closed -$654K 1835
2018
Q4
$654K Sell
12,347
-192,371
-94% -$10.2M ﹤0.01% 1048
2018
Q3
$12.3M Buy
204,718
+127,264
+164% +$7.62M 0.03% 376
2018
Q2
$3.33M Buy
77,454
+57,940
+297% +$2.49M 0.01% 608
2018
Q1
$681K Buy
19,514
+5,733
+42% +$200K ﹤0.01% 920
2017
Q4
$500K Buy
+13,781
New +$500K ﹤0.01% 1068